Preparation, chromatographic evaluation and biodistribution of 99m Tc-procainamide as a radiopharmaceutical for heart imaging
Abstract Procainamide (4-amino-N-[2-(diethylamino) ethyl] benzamide) is a sodium channel blocker, which acts as an effective antiarrhythmic agent used in the treatment of a variety of atrial and ventricular arrhythmias. The aim of this study was to prepare 99m Tc-procainamide complex, apply differen...
Saved in:
Published in | Radiochimica acta Vol. 105; no. 3; pp. 215 - 223 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
01.03.2017
|
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract
Procainamide (4-amino-N-[2-(diethylamino) ethyl] benzamide) is a sodium channel blocker, which acts as an effective antiarrhythmic agent used in the treatment of a variety of atrial and ventricular arrhythmias. The aim of this study was to prepare
99m
Tc-procainamide complex, apply different chromatographic techniques for the assay of radiolabeling yield and study its biodistribution as a novel radiopharmaceutical for heart imaging.
99m
Tc-procainamide was obtained with a maximum labeling yield of 95.76±0.20%
via
direct labeling method under optimum conditions of 200 μg of procainamide, 300 μL of buffer (carbonate) at pH 11, 30 μg SnCl
2
·2H
2
O at room temperature (25°C) for 15 min. In terms of
in vitro
stability, the complex was stable for 3 h. Chromatographic evaluation using paper chromatography, thin layer chromatography, gel chromatography, and high performance liquid chromatography showed reliable results for measuring the radiochemical yield. Biodistribution study of
99m
Tc-procainamide showed ratios of heart/lung and heart/liver (6.38±1.50, 2.06±0.31, respectively at 30 min post injection) which was comparable to that of
99m
Tc-sestamibi (7.4±2.00, 0.97±0.10, respectively at 60 min,
P
<0.05). |
---|---|
ISSN: | 0033-8230 2193-3405 |
DOI: | 10.1515/ract-2015-2558 |